In summary, the analyses of human gastric cancer PDOs confirmed the findings from the RAS‐activated murine organoid model and substantiated the association between the presence of an RTK/MAPK alteration and HDAC inhibitor sensitivity. Here, HDAC9 is linked to gastric cancer.